Home > Insider Trading > Filing (0001104659-14-006845)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1399529	Dicerna Pharmaceuticals Inc	DRNA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1277503	Yasunori Kaneko	525 University Avenue Palo Alto CA 94301	No	No	Yes	No
1296771	Gordon John Freund	525 University Avenue Palo Alto CA 94301	No	No	Yes	No
1419187	Skyline Venture Partners V Lp	525 University Avenue Palo Alto CA 94301	No	No	Yes	No
1434887	Skyline Venture Management V, Llc	525 University Avenue Palo Alto CA 94301	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-02-04	312,000	$0.00	312,000	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2014-02-04	179,322	$0.00	491,322	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2014-02-04	1,043,429	$0.00	1,534,751	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2014-02-04	200,000	$15.00	1,734,751	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2014-02-04	312,000	$0.00	312,000	$0.00
Common Stock	Series B Preferred Stock	Disposition	2014-02-04	179,322	$0.00	179,322	$0.00
Common Stock	Series C Preferred Stock	Disposition	2014-02-04	1,043,429	$0.00	1,043,429	$0.00
Common Stock	Common Stock Warrant	Acquisiton	2014-02-04	755	$0.00	755	$250.00
Common Stock	Series C Preferred Stock Warrants	Disposition	2014-02-04	21,697	$0.00	21,697	$7.00
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2014-02-04	21,697	$0.00	21,697	$7.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
755	No	4	C	Indirect
0	No	4	C	Indirect
21,697	No	4	C	Indirect

Footnotes

Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted into one share of the Issuer's Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
These securities are held by Skyline Ventures Partners V, L.P. ("Skyline V"). John G. Freund, M.D. and Yasunori Kaneko, M.D. are Managing Directors of Skyline Venture Management V, LLC, the general partner of Skyline V, and may be deemed to share voting and dispositive power over the shares held by Skyline V. Stephen Hoffman, M.D., Ph.D. is a member of Skyline Venture Management V, LLC and may be deemed to share voting and dispositive power over the shares held by Skyline V. Each of Drs. Freund, Kaneko and Hoffman disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
Warrants will expire June 17, 2020.
Warrants will expire June 17, 2020.